Gonorrhoea: Drug Resistance in Australia

Australian Federation of AIDS Organisations (AFAO), 26 June 2018

There has long been concern globally about the potential emergence of drug resistant STIs. In response, the World Health Organisation released new treatment guidelines for three common STIs – chlamydia, gonorrhoea and syphilis – in 2016.

At present, strains resistant to first line treatment of syphilis and chlamydia are not common and not a concern in Australia. There is, however, a growing level of concern about gonorrhoea. This paper therefore focuses on the likelihood and implications of the emergence of drug resistant cases of gonorrhoea in Australia. It also highlights treatment options in Australia and current and emerging strategies for preventing drug resistant gonorrhoea.

Download paper: AFAO Brief – Gonorrhoea – Drug Resistance in Australia – 26 June 2018

Stillbirth more frequent in women with HIV in UK than in general population

nam/aidsmap, 01 August 2017

The stillbirth rate among women living with HIV in the UK and Ireland from 2007 to 2015 was more than twice that of the general population, Graziella Favarato, presenting on behalf of the National Study of HIV in Pregnancy and Childhood (NSHPC), told participants at the 9th International AIDS Society Conference on HIV Science (IAS 2017) in Paris last week.

Most women originated from a sub-Saharan African country, accounting for 0.9% of stillbirths (71/7752) while stillbirth among women from Europe or westernised countries accounted for 0.4% (8/2004).

NSW introduces Dried Blood Spot test for HIV

NSW Health, December 1, 2016

A new HIV testing service has launched in NSW, allowing people to mail off a sample of their blood and receive their results by phone, SMS or email. There’s no need to visit a doctor, clinic or pathology centre. 

DBS HIV testing is for people living in New South Wales, who are over 16 years old. The test is for gay and other men who have sex with men, people from Africa or Asia and people who have current or previous sexual partners from Africa or Asia.

For other groups of people, conventional laboratory HIV testing may be more suitable.

 

HIV prevention drug PrEP being tested on high-risk adolescents

Sydney Morning Herald, July 21 2016

A preventative HIV drug being used by thousands of gay men in Australia is being tested on teenagers at high risk of the virus.

Studies have shown that PrEP (pre-exposure prophylaxis) offers near complete protection against HIV if taken properly every day. Researchers are now testing it on young people in South Africa and the US.

Read more here

New pilot project to improve hep B outcomes for at-risk patients

Burnet Institute, 28 June, 2016

Improved screening of patients at risk of hepatitis B is the aim of a new pilot project underway in Victoria, with early diagnosis and treatment crucial to reduce the risk of liver cancer.

Cancer Council Victoria and Burnet Institute’s Screening for Hepatitis in At-Risk Populations (SHARP) project will trial four new interventions to help diagnose hepatitis B in GP clinics.

The project is targeting patients from countries where hepatitis B is endemic, including Somalia, Sudan, China and Vietnam.

  • Read more here
  • SHARP project details here

New USPSTF Recommendation on Hepatitis B Screening for People at High-Risk

AIDS.gov blog, May 27 2014

New USPSTF Recommendation on Hepatitis B Screening for People at High-Risk

– See more at: http://blog.aids.gov/2014/05/new-uspstf-recommendation-on-hepatitis-b-screening-for-people-at-high-risk.html#sthash.NMGWG8vb.dpuf

New USPSTF Recommendation on Hepatitis B Screening for People at High-Risk

– See more at: http://blog.aids.gov/2014/05/new-uspstf-recommendation-on-hepatitis-b-screening-for-people-at-high-risk.html#sthash.NMGWG8vb.dpuf

The U.S. Preventive Services Task Force has published its final recommendation statement on screening for hepatitis B virus (HBV) infection in individuals at high risk.

Read more

the U.S. Preventive Services Task Force (Task Force) Exit Disclaimer published its final recommendation statement on screening for hepatitis B virus (HBV) infection in individuals at high risk. – See more at: http://blog.aids.gov/2014/05/new-uspstf-recommendation-on-hepatitis-b-screening-for-people-at-high-risk.html#sthash.NMGWG8vb.dpuf